Summary

Broadly, per AAFP/AAP/ACOG/IDSA (via AMA-VIP), not just narrow risk groups: all adults 19+ (extra emphasis 65+, second dose 6mo later); kids 6-23mo universally, ages 2-18 if high-risk or by choice; pregnant/postpartum/lactating people (ACOG, any trimester); immunocompromised patients; health care workers.

Responding to @jonathanwarden.com's reply to @elizabethjacobs.bsky.social's post.

Research Analysis

Bottom line

According to major U.S. medical professional associations — explicitly setting aside CDC/ACIP/HHS federal guidance, as requested — the consensus 2026‑2027 recommendation is that the updated COVID‑19 vaccine should be offered broadly, not just to narrow risk groups:

• All adults 19 and older should be offered an annual updated COVID‑19 vaccine, with added emphasis for adults 65+, people at increased risk of severe disease, and anyone who has never been vaccinated. The recommendation covers all adults 19 and older, with added weight for patients 65 and older, patients at increased risk of severe infection and patients who have never received a COVID-19 vaccine.[1] Adults 65 and older should receive a second dose of the updated vaccine six months after the first.[1]
• Children 6–23 months are universally recommended to get the vaccine, while for ages 2–18 it's risk‑based (recommended for high‑risk children, and available on request/shared decision‑making for others). COVID-19 vaccination is universally recommended for children aged 6–23 months, with risk-based and elective recommendations for ages 2–17 years.[2] This aligns across societies: AAFP recommends vaccination for all children 6 to 23 months and a risk-based single-dose approach for ages 2 to 18, which the academy says aligns with AAP's 2026 recommendation.[1]
• Pregnant, postpartum, lactating, and pregnancy‑contemplating individuals should routinely get the COVID vaccine (any trimester), per ACOG. The American College of Obstetricians and Gynecologists (ACOG) has released updated guidance that strongly recommends vaccination against COVID-19, respiratory syncytial virus (RSV), and influenza for all women who are pregnant, postpartum, or contemplating pregnancy ahead of the 2026–27 respiratory virus season.[3]
• Immunocompromised patients (transplant recipients, hematologic malignancy, autoimmune disease on immunosuppressants/biologics, HIV with severe immune suppression) have specific IDSA guidance recommending vaccination. These recommendations address patients who have a hematologic malignancy, primary immunodeficiency, autoimmune disease treated with immunosuppressants or biologics, or HIV with severe immunosuppression (CD4 <15% or <200/mm³), as well as patients who are recipients of solid organ transplants (SOT), hem[atopoietic stem cell transplant recipients, etc.][4]
• Health care workers are also specifically called out for annual vaccination due to occupational exposure. Health care professionals should receive annual updated influenza and COVID-19 vaccination, the academy says, citing repeated occupational exposure and contact with patients at high risk of severe disease.[1]

This is broader than current federal (HHS/CDC/ACIP) guidance, which under RFK Jr.'s leadership has narrowed some recommendations (e.g., dropping the routine pregnancy recommendation, and shifting pediatric guidance to "consult your doctor" without an affirmative recommendation) — but the question asked specifically excludes that federal layer, so it is not the basis of the answer above.

Background: why professional societies are issuing independent guidance

Historically ACIP/CDC set the baseline U.S. immunization schedule. Amid controversy over changes to federal vaccine policy under the current administration, major clinical societies have begun publishing their own evidence-based recommendations independent of the federal government. This is the first time the organization has released an immunization schedule independent of the US Centers for Disease Control and Prevention, evidence of the growing rift between the professional health society and CDC.[5] News coverage from the past day frames this explicitly: Major medical groups have released their vaccine recommendations for the 2026-2027 respiratory virus season, stepping in as federal health agencies face credibility concerns under the influence of anti-vaccine advocate Robert F. Kennedy Jr.[6]

A coordinated, cross-society evidence review effort underlies much of this: A coalition of leading medical groups has released its own vaccine recommendation for the 2026-27 respiratory viral season based on their independent evidence review of existing data. The Vaccine Integrity Project (VIP) and American Medical Association (AMA) collaborated on evidence reviews for the vaccines targeting COVID-19, RSV and the flu.[7] Their key conclusion: "The newest evidence continues to demonstrate that immunization provides meaningful protection against hospitalization, severe illness and death. The degree of protection varies by virus, vaccine or immunization product, population, season and circulating strains," VIP said in its key findings.[7] They also stated "No new safety concerns were identified in comparative studies evaluating currently recommended immunizations. The findings are consistent with the well-established safety profiles of influenza and COVID-19 vaccines and the growing safety evidence for RSV immunizations."[7] These consolidated recommendations are published at SpreadTheFacts.org and summarized on the AMA's site, which pulls together guidance from AAFP, AAP, ACOG, and IDSA. This resource includes the current flu, COVID-19, and RSV immunization recommendations from the American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America into a single printable reference for you and your patients.[8]

Detailed recommendations by population

Adults (AAFP / AMA-consolidated): Influenza (seasonal flu) annual flu vaccine for all adults age 19+; COVID-19 annual updated COVID-19 vaccine; RSV one-time RSV vaccine for adults age 50-74 at increased risk of severe RSV.[8] For adults 65+: Annual updated COVID-19 vaccine for adults 65+, followed by a second dose 6 months later to boost protection; RSV one-time vaccine recommended for adults age 50-74 at increased risk and all adults age 75+.[8]

Children (AAP/AAFP): All young children ages 6-23 months and children 2-18 years in certain risk groups or if desired should get the COVID-19 vaccine.[8] Similarly, per AAFP: AAFP recommends vaccination for all children 6 to 23 months and a risk-based single-dose approach for ages 2 to 18, which the academy says aligns with AAP's 2026 recommendation. The AAP's broader immunization schedule reasoning: COVID-19 vaccination is universally recommended for children aged 6–23 months, with risk-based and elective recommendations for ages 2–17 years. AAP infectious disease experts emphasized that no new data support removing routine recommendations for vaccines such as hepatitis A and B, influenza, COVID-19, and meningococcal disease. "And nothing has changed. Therefore, we continue to recommend those vaccines."[2] The 2026 AAP schedule has been formally endorsed by 12 organizations, including the American College of Obstetricians and [Gynecologists].[2]

Pregnancy and lactation (ACOG): ACOG strongly recommends COVID-19, RSV, and influenza vaccination for pregnant, postpartum, and pregnancy-contemplating individuals, with all 3 vaccines safe to coadminister.[3] The clinical rationale cites substantial benefit: Based on the evidence review, vaccination reduced the risk of severe disease in pregnancy, hospitalization, and adverse outcomes including stillbirth and preterm birth. Findings revealed that maternal COVID-19 vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58%, and extended protection to infants, with vaccine effectiveness of 50% to 54% against COVID-related hospital contacts in the first 2 months of life regardless of which trimester the vaccine was received.[3] ACOG issued this as a formal reaffirmation earlier in 2026: ACOG released updated guidance on COVID-19 vaccination, continuing to recommend the routine administration of updated COVID-19 vaccines to people who are pregnant, recently pregnant, considering pregnancy, or lactating.[9] ACOG's leadership explicitly framed this as independent of federal policy: "Despite changes in federal vaccine recommendations, ACOG's position remains clear, evidence-based, and aligned with the broader public health and medical community," said ACOG President Steven J. Fleischman, MD, MBA, FACOG.[9] Notably, uptake has fallen sharply even as the recommendation stands: 11.1% of pregnant women received a COVID-19 vaccine in 2025–26, down 25.7% from the prior year.[3]

Immunocompromised individuals (IDSA): The Infectious Diseases Society of America (IDSA) has released recommendations for COVID-19 vaccination of individuals who have impaired immune systems either due to their underlying disease (e.g., HIV, malignancy) or due to the medications they must take (e.g., solid organ transplant).[4] These recommendations specifically target patients who have a hematologic malignancy, primary immunodeficiency, autoimmune disease treated with immunosuppressants or biologics, or HIV with severe immunosuppression (CD4 <15% or <200/mm³), as well as patients who are recipients of solid organ transplants (SOT), hem[atopoietic stem cell transplants, etc.][4]

Health care workers (AAFP): Health care professionals should receive annual updated influenza and COVID-19 vaccination, the academy says, citing repeated occupational exposure and contact with patients at high risk of severe disease.

How this differs from, and responds to, federal guidance

The societies' independent stance is a direct reaction to changes at HHS/CDC. As one report notes, on COVID vaccines, some medical groups are going further than the CDC. While the CDC recommends parents of children under 18 consult their doctor, several specialty groups say the COVID vaccine should be given to children 6 months to 23 months old. For children ages 2 to 18, those groups recommend vaccination if the child is at high risk of severe COVID infection.[10] A public-health expert commented on the significance of this shift: "The single biggest change is that the recommendations are not now coming from the federal government. They're coming from professional societies of various different doctors. And I think that's the best situation we could hope for because the ACIP, the Advisory Committee on Immunization Practices, is basically in shambles, has been basically taken over by RFK Jr. and is not really a valid institution," Adalja said.[11]

It's worth noting these society recommendations do not carry the same regulatory/insurance weight as ACIP: CDC contracts for a vaccine only after ACIP passes a VFC resolution, an authority Congress gave the committee in 1993. A recommendation issued by AAFP, AAP, ACOG or IDSA triggers neither [automatic government purchase nor certain insurance coverage mandates].[1] This is a practical caveat: professional-society recommendations are clinically authoritative and widely followed by physicians, but insurance coverage and vaccine-program eligibility in the U.S. can still hinge on the separate federal ACIP/CDC process.

Notes on sourcing and any uncertainty

• These figures come from very recent (within the last 1–2 days) reporting and society statements dated September 2026, consistent with the "2026‑2027 season" framing in your ancestor post's cited JAMA article.
• There is broad alignment across AAFP, AAP, ACOG, and IDSA (as consolidated by AMA/Vaccine Integrity Project) on the core recommendations described above; I did not find major disagreement among these societies on the core COVID-19 recommendations, though RSV recommendations vary somewhat by specialty focus (e.g., OB-GYN groups emphasize pregnancy timing). RSV recommendations vary by specialty. OB-GYNs are focused on pregnant women, noting the RSV season now runs from September through March — an extension from the previous September-to-January window.[10]
• I have not independently verified every numeric detail (e.g., the "58%" ED-visit reduction or "50–54%" infant VE figures) against the primary studies; these are as reported by contemporaryobgyn.net summarizing ACOG's evidence review, not from the primary paper itself. Given the specificity of these effectiveness numbers, if precision matters for your purposes, I'd recommend checking ACOG's full statement or the underlying studies it cites.
• The 2026-2027 JAMA review referenced in the ancestor post is a real, recent publication and is consistent with (and appears to be a key input into) the professional societies' recommendations described here, though this reply focuses specifically on what professional associations recommend rather than re-analyzing that paper's findings.

Sources

1. AAFP issues fall vaccine recommendations amid competing guidance ...
2. American Academy of Pediatrics releases 2026 childhood immunization ...
3. ACOG's 2026-27 respiratory virus immunization recommendations in ...
4. Locating the Latest Science-based Vaccine Recommendations
5. Leading OB-GYN society breaks from CDC on recommended vaccines ...
6. Medical groups release 2026-2027 flu, COVID and RSV vaccine ...
7. Leading medical groups update flu, COVID vaccine recommendations ...
8. Vaccine recommendations
9. ACOG Reaffirms Strong Recommendation for COVID-19 Vaccination during ...
10. Medical groups release 2026-2027 flu, COVID and RSV vaccine ...
11. Medical groups release 2026-2027 flu, COVID and RSV vaccine ...

Continue this conversation in Claude

How this response was produced

Prompt template: CONTEXT_BOT_STRUCTURE_V2 Semantic version: 2.0.0 SHA-256: 1cc52c1fcbce28a8dbab9e680d7077b01024960e3ca00d8d153b4bdae665a23f

Hidden model reasoning is not available and is not part of this page. The same prompt and parameters do not guarantee an identical Claude response.

Messages API parameters

• anthropic-version: 2023-06-01
• model: claude-sonnet-5
• max_tokens: 4096
• output_format: json_schema
• cache_control: ephemeral
• stream: false
• continuation: false
• length_repair: false

Canonical thread

The first user message sent to the Messages API:

STRUCTURE_OUTPUT

Canonical thread:

CONTEXT_BOT_THREAD_V2

[ancestor]
Author: elizabethjacobs.bsky.social (did:plc:flwgfsh2mhpoqwjwwt2mesjv)
URI: at://did:plc:flwgfsh2mhpoqwjwwt2mesjv/app.bsky.feed.post/3muni66cn422j
Text:
Just in time for the 2026-2027 vaccines, a new review shows that COVID19 vaccination significantly reduces the risk of severe illness and hospitalization across all age groups, including kids. 

Pregnant women were also protected, as were their babies. 

Don’t forget to schedule your vaccination!
External link: COVID-19 Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season
External URI: https://jamanetwork.com/journals/jama/fullarticle/2853778

[invocation]
Author: jonathanwarden.com (did:plc:33avz2l7y5scw3abq3lmylns)
URI: at://did:plc:33avz2l7y5scw3abq3lmylns/app.bsky.feed.post/3munl4nz6k226
Text:
@getcontext.bot Who should take the COVID vaccine for 2026-2027 according to professional associations (ignore official U.S. federal guidance)

Research writeup:

## Bottom line

According to major U.S. medical professional associations — explicitly setting aside CDC/ACIP/HHS federal guidance, as requested — the consensus 2026‑2027 recommendation is that the **updated COVID‑19 vaccine should be offered broadly, not just to narrow risk groups**:

- **All adults 19 and older** should be offered an annual updated COVID‑19 vaccine, with added emphasis for adults 65+, people at increased risk of severe disease, and anyone who has never been vaccinated. The recommendation covers all adults 19 and older, with added weight for patients 65 and older, patients at increased risk of severe infection and patients who have never received a COVID-19 vaccine.[[1]](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance) Adults 65 and older should receive a second dose of the updated vaccine six months after the first.[[1]](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance)
- **Children 6–23 months** are universally recommended to get the vaccine, while for **ages 2–18** it's risk‑based (recommended for high‑risk children, and available on request/shared decision‑making for others). COVID-19 vaccination is universally recommended for children aged 6–23 months, with risk-based and elective recommendations for ages 2–17 years.[[2]](https://www.contemporaryobgyn.net/view/american-academy-of-pediatrics-releases-2026-childhood-immunization-scheduled) This aligns across societies: AAFP recommends vaccination for all children 6 to 23 months and a risk-based single-dose approach for ages 2 to 18, which the academy says aligns with AAP's 2026 recommendation.[[1]](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance)
- **Pregnant, postpartum, lactating, and pregnancy‑contemplating individuals** should routinely get the COVID vaccine (any trimester), per ACOG. The American College of Obstetricians and Gynecologists (ACOG) has released updated guidance that strongly recommends vaccination against COVID-19, respiratory syncytial virus (RSV), and influenza for all women who are pregnant, postpartum, or contemplating pregnancy ahead of the 2026–27 respiratory virus season.[[3]](https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy)
- **Immunocompromised patients** (transplant recipients, hematologic malignancy, autoimmune disease on immunosuppressants/biologics, HIV with severe immune suppression) have specific IDSA guidance recommending vaccination. These recommendations address patients who have a hematologic malignancy, primary immunodeficiency, autoimmune disease treated with immunosuppressants or biologics, or HIV with severe immunosuppression (CD4 <15% or <200/mm³), as well as patients who are recipients of solid organ transplants (SOT), hem[atopoietic stem cell transplant recipients, etc.][[4]](https://www.chop.edu/vaccine-update-healthcare-professionals/locating-latest-science-based-vaccine-recommendations)
- **Health care workers** are also specifically called out for annual vaccination due to occupational exposure. Health care professionals should receive annual updated influenza and COVID-19 vaccination, the academy says, citing repeated occupational exposure and contact with patients at high risk of severe disease.[[1]](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance)

This is broader than current federal (HHS/CDC/ACIP) guidance, which under RFK Jr.'s leadership has narrowed some recommendations (e.g., dropping the routine pregnancy recommendation, and shifting pediatric guidance to "consult your doctor" without an affirmative recommendation) — but the question asked specifically excludes that federal layer, so it is not the basis of the answer above.

## Background: why professional societies are issuing independent guidance

Historically ACIP/CDC set the baseline U.S. immunization schedule. Amid controversy over changes to federal vaccine policy under the current administration, major clinical societies have begun publishing their own evidence-based recommendations independent of the federal government. This is the first time the organization has released an immunization schedule independent of the US Centers for Disease Control and Prevention, evidence of the growing rift between the professional health society and CDC.[[5]](https://www.cidrap.umn.edu/influenza-vaccines/leading-ob-gyn-society-breaks-cdc-recommended-vaccines-pregnant-women-including) News coverage from the past day frames this explicitly: Major medical groups have released their vaccine recommendations for the 2026-2027 respiratory virus season, stepping in as federal health agencies face credibility concerns under the influence of anti-vaccine advocate Robert F. Kennedy Jr.[[6]](https://www.kpax.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)

A coordinated, cross-society evidence review effort underlies much of this: A coalition of leading medical groups has released its own vaccine recommendation for the 2026-27 respiratory viral season based on their independent evidence review of existing data. The Vaccine Integrity Project (VIP) and American Medical Association (AMA) collaborated on evidence reviews for the vaccines targeting COVID-19, RSV and the flu.[[7]](https://thehill.com/policy/healthcare/6068925-ama-vip-vaccine-recommendations/) Their key conclusion: "The newest evidence continues to demonstrate that immunization provides meaningful protection against hospitalization, severe illness and death. The degree of protection varies by virus, vaccine or immunization product, population, season and circulating strains," VIP said in its key findings.[[7]](https://thehill.com/policy/healthcare/6068925-ama-vip-vaccine-recommendations/) They also stated "No new safety concerns were identified in comparative studies evaluating currently recommended immunizations. The findings are consistent with the well-established safety profiles of influenza and COVID-19 vaccines and the growing safety evidence for RSV immunizations."[[7]](https://thehill.com/policy/healthcare/6068925-ama-vip-vaccine-recommendations/) These consolidated recommendations are published at SpreadTheFacts.org and summarized on the AMA's site, which pulls together guidance from AAFP, AAP, ACOG, and IDSA. This resource includes the current flu, COVID-19, and RSV immunization recommendations from the American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and the Infectious Diseases Society of America into a single printable reference for you and your patients.[[8]](https://www.ama-assn.org/amaone/vaccine-recommendations)

## Detailed recommendations by population

**Adults (AAFP / AMA-consolidated):**
Influenza (seasonal flu) annual flu vaccine for all adults age 19+; COVID-19 annual updated COVID-19 vaccine; RSV one-time RSV vaccine for adults age 50-74 at increased risk of severe RSV.[[8]](https://www.ama-assn.org/amaone/vaccine-recommendations) For adults 65+: Annual updated COVID-19 vaccine for adults 65+, followed by a second dose 6 months later to boost protection; RSV one-time vaccine recommended for adults age 50-74 at increased risk and all adults age 75+.[[8]](https://www.ama-assn.org/amaone/vaccine-recommendations)

**Children (AAP/AAFP):**
All young children ages 6-23 months and children 2-18 years in certain risk groups or if desired should get the COVID-19 vaccine.[[8]](https://www.ama-assn.org/amaone/vaccine-recommendations) Similarly, per AAFP: AAFP recommends vaccination for all children 6 to 23 months and a risk-based single-dose approach for ages 2 to 18, which the academy says aligns with AAP's 2026 recommendation. The AAP's broader immunization schedule reasoning: COVID-19 vaccination is universally recommended for children aged 6–23 months, with risk-based and elective recommendations for ages 2–17 years. AAP infectious disease experts emphasized that no new data support removing routine recommendations for vaccines such as hepatitis A and B, influenza, COVID-19, and meningococcal disease. "And nothing has changed. Therefore, we continue to recommend those vaccines."[[2]](https://www.contemporaryobgyn.net/view/american-academy-of-pediatrics-releases-2026-childhood-immunization-scheduled) The 2026 AAP schedule has been formally endorsed by 12 organizations, including the American College of Obstetricians and [Gynecologists].[[2]](https://www.contemporaryobgyn.net/view/american-academy-of-pediatrics-releases-2026-childhood-immunization-scheduled)

**Pregnancy and lactation (ACOG):**
ACOG strongly recommends COVID-19, RSV, and influenza vaccination for pregnant, postpartum, and pregnancy-contemplating individuals, with all 3 vaccines safe to coadminister.[[3]](https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy) The clinical rationale cites substantial benefit: Based on the evidence review, vaccination reduced the risk of severe disease in pregnancy, hospitalization, and adverse outcomes including stillbirth and preterm birth. Findings revealed that maternal COVID-19 vaccination lowered the risk of emergency department and urgent care visits for pregnant women by 58%, and extended protection to infants, with vaccine effectiveness of 50% to 54% against COVID-related hospital contacts in the first 2 months of life regardless of which trimester the vaccine was received.[[3]](https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy) ACOG issued this as a formal reaffirmation earlier in 2026: ACOG released updated guidance on COVID-19 vaccination, continuing to recommend the routine administration of updated COVID-19 vaccines to people who are pregnant, recently pregnant, considering pregnancy, or lactating.[[9]](https://www.acog.org/news/news-releases/2026/03/acog-reaffirms-strong-recommendation-covid-19-vaccination-pregnancy) ACOG's leadership explicitly framed this as independent of federal policy: "Despite changes in federal vaccine recommendations, ACOG's position remains clear, evidence-based, and aligned with the broader public health and medical community," said ACOG President Steven J. Fleischman, MD, MBA, FACOG.[[9]](https://www.acog.org/news/news-releases/2026/03/acog-reaffirms-strong-recommendation-covid-19-vaccination-pregnancy) Notably, uptake has fallen sharply even as the recommendation stands: 11.1% of pregnant women received a COVID-19 vaccine in 2025–26, down 25.7% from the prior year.[[3]](https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy)

**Immunocompromised individuals (IDSA):**
The Infectious Diseases Society of America (IDSA) has released recommendations for COVID-19 vaccination of individuals who have impaired immune systems either due to their underlying disease (e.g., HIV, malignancy) or due to the medications they must take (e.g., solid organ transplant).[[4]](https://www.chop.edu/vaccine-update-healthcare-professionals/locating-latest-science-based-vaccine-recommendations) These recommendations specifically target patients who have a hematologic malignancy, primary immunodeficiency, autoimmune disease treated with immunosuppressants or biologics, or HIV with severe immunosuppression (CD4 <15% or <200/mm³), as well as patients who are recipients of solid organ transplants (SOT), hem[atopoietic stem cell transplants, etc.][[4]](https://www.chop.edu/vaccine-update-healthcare-professionals/locating-latest-science-based-vaccine-recommendations)

**Health care workers (AAFP):**
Health care professionals should receive annual updated influenza and COVID-19 vaccination, the academy says, citing repeated occupational exposure and contact with patients at high risk of severe disease.

## How this differs from, and responds to, federal guidance

The societies' independent stance is a direct reaction to changes at HHS/CDC. As one report notes, on COVID vaccines, some medical groups are going further than the CDC. While the CDC recommends parents of children under 18 consult their doctor, several specialty groups say the COVID vaccine should be given to children 6 months to 23 months old. For children ages 2 to 18, those groups recommend vaccination if the child is at high risk of severe COVID infection.[[10]](https://www.newschannel5.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season) A public-health expert commented on the significance of this shift: "The single biggest change is that the recommendations are not now coming from the federal government. They're coming from professional societies of various different doctors. And I think that's the best situation we could hope for because the ACIP, the Advisory Committee on Immunization Practices, is basically in shambles, has been basically taken over by RFK Jr. and is not really a valid institution," Adalja said.[[11]](https://www.wtxl.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)

It's worth noting these society recommendations do not carry the same regulatory/insurance weight as ACIP: CDC contracts for a vaccine only after ACIP passes a VFC resolution, an authority Congress gave the committee in 1993. A recommendation issued by AAFP, AAP, ACOG or IDSA triggers neither [automatic government purchase nor certain insurance coverage mandates].[[1]](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance) This is a practical caveat: professional-society recommendations are clinically authoritative and widely followed by physicians, but insurance coverage and vaccine-program eligibility in the U.S. can still hinge on the separate federal ACIP/CDC process.

## Notes on sourcing and any uncertainty

- These figures come from very recent (within the last 1–2 days) reporting and society statements dated September 2026, consistent with the "2026‑2027 season" framing in your ancestor post's cited JAMA article.
- There is broad **alignment** across AAFP, AAP, ACOG, and IDSA (as consolidated by AMA/Vaccine Integrity Project) on the core recommendations described above; I did not find major disagreement among these societies on the core COVID-19 recommendations, though RSV recommendations vary somewhat by specialty focus (e.g., OB-GYN groups emphasize pregnancy timing). RSV recommendations vary by specialty. OB-GYNs are focused on pregnant women, noting the RSV season now runs from September through March — an extension from the previous September-to-January window.[[10]](https://www.newschannel5.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)
- I have not independently verified every numeric detail (e.g., the "58%" ED-visit reduction or "50–54%" infant VE figures) against the primary studies; these are as reported by contemporaryobgyn.net summarizing ACOG's evidence review, not from the primary paper itself. Given the specificity of these effectiveness numbers, if precision matters for your purposes, I'd recommend checking ACOG's full statement or the underlying studies it cites.
- The 2026-2027 JAMA review referenced in the ancestor post is a real, recent publication and is consistent with (and appears to be a key input into) the professional societies' recommendations described here, though this reply focuses specifically on what professional associations recommend rather than re-analyzing that paper's findings.

## Sources

1. [AAFP issues fall vaccine recommendations amid competing guidance ...](https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance)
2. [American Academy of Pediatrics releases 2026 childhood immunization ...](https://www.contemporaryobgyn.net/view/american-academy-of-pediatrics-releases-2026-childhood-immunization-scheduled)
3. [ACOG's 2026-27 respiratory virus immunization recommendations in ...](https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy)
4. [Locating the Latest Science-based Vaccine Recommendations](https://www.chop.edu/vaccine-update-healthcare-professionals/locating-latest-science-based-vaccine-recommendations)
5. [Leading OB-GYN society breaks from CDC on recommended vaccines ...](https://www.cidrap.umn.edu/influenza-vaccines/leading-ob-gyn-society-breaks-cdc-recommended-vaccines-pregnant-women-including)
6. [Medical groups release 2026-2027 flu, COVID and RSV vaccine ...](https://www.kpax.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)
7. [Leading medical groups update flu, COVID vaccine recommendations ...](https://thehill.com/policy/healthcare/6068925-ama-vip-vaccine-recommendations/)
8. [Vaccine recommendations](https://www.ama-assn.org/amaone/vaccine-recommendations)
9. [ACOG Reaffirms Strong Recommendation for COVID-19 Vaccination during ...](https://www.acog.org/news/news-releases/2026/03/acog-reaffirms-strong-recommendation-covid-19-vaccination-pregnancy)
10. [Medical groups release 2026-2027 flu, COVID and RSV vaccine ...](https://www.newschannel5.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)
11. [Medical groups release 2026-2027 flu, COVID and RSV vaccine ...](https://www.wtxl.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season)

Citation URLs (allowlist; do not invent others):
- https://www.medicaleconomics.com/view/aafp-issues-fall-vaccine-recommendations-amid-competing-guidance
- https://www.contemporaryobgyn.net/view/american-academy-of-pediatrics-releases-2026-childhood-immunization-scheduled
- https://www.contemporaryobgyn.net/view/acog-2026-27-respiratory-virus-immunization-recommendations-pregnancy
- https://www.chop.edu/vaccine-update-healthcare-professionals/locating-latest-science-based-vaccine-recommendations
- https://www.cidrap.umn.edu/influenza-vaccines/leading-ob-gyn-society-breaks-cdc-recommended-vaccines-pregnant-women-including
- https://www.kpax.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season
- https://thehill.com/policy/healthcare/6068925-ama-vip-vaccine-recommendations/
- https://www.ama-assn.org/amaone/vaccine-recommendations
- https://www.acog.org/news/news-releases/2026/03/acog-reaffirms-strong-recommendation-covid-19-vaccination-pregnancy
- https://www.newschannel5.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season
- https://www.wtxl.com/health/medical-groups-release-2026-2027-flu-covid-and-rsv-vaccine-recommendations-for-fall-season